Effect of vitamin supplements on HIV shedding in breast milk

American Journal of Clinical Nutrition

Volumn 92, Issue 4, 2010, Pages 881-886

  Villamor, Eduardo ^a,b   Koulinska, Irene N ^b   Aboud, Said ^d   Murrin, Clare ^b   Bosch, Ronald J ^c   Manji, Karim P ^d   Fawzi, Wafaie W ^b  

^a UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c CENTER FOR BIOSTATISTICS IN AIDS RESEARCH   (United States)

^d MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; BETA CAROTENE; CYANOCOBALAMIN; FOLIC ACID; MULTIVITAMIN; NICOTINIC ACID; PLACEBO; PYRIDOXINE; RETINOL; RIBOFLAVIN; THIAMINE; VITAMIN B COMPLEX; VITAMIN;

ADULT; ARTICLE; BREAST MILK; DELIVERY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; LACTATION; MAJOR CLINICAL STUDY; NONHUMAN; RANDOMIZED CONTROLLED TRIAL; TANZANIA; VIRUS LOAD; VIRUS SHEDDING; VITAMIN SUPPLEMENTATION; BREAST FEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE TRANSMISSION; DRUG EFFECT; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISOLATION AND PURIFICATION; PREGNANCY; RISK FACTOR; VIROLOGY;

HUMAN IMMUNODEFICIENCY VIRUS 1;

BETA CAROTENE; BREAST FEEDING; DIETARY SUPPLEMENTS; FEMALE; HIV; HIV INFECTIONS; HUMANS; MILK, HUMAN; PREGNANCY; RISK FACTORS; TANZANIA; VIRAL LOAD; VIRUS SHEDDING; VITAMIN A; VITAMINS;

EID: 78049445045     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.2010.29339     Document Type: Article

References (32)

1. UNAIDS. AIDS epidemic update. Geneva, Switzerland: United Nations Program on HIV/AIDS, 2009.
2. Coutsoudis A, Dabis F, Fawzi W, et al. Late postnatal transmission of HIV-1 in breast-fed children: an individual patient data meta-analysis. J Infect Dis 2004;189:2154-66.
3. Becquet R, Bland R, Leroy V, et al. Duration, pattern of breastfeeding and postnatal transmission of HIV: pooled analysis of individual data from West and South African cohorts. PLoS ONE 2009;4:e7397.
4. Becquet R, Ekouevi DK, Arrive E, et al. Universal antiretroviral therapy for pregnant and breast-feeding HIV-1-infected women: towards the elimination of mother-to-child transmission of HIV-1 in resource-limited settings. Clin Infect Dis 2009;49:1936-45.
5. Fawzi WW, Msamanga GI, Hunter D, et al. Randomized trial of vitamin supplements in relation to transmission of HIV-1 through breast-feeding and early child mortality. AIDS 2002;16:1935-44.
6. Fawzi W, Msamanga G, Antelman G, et al. Effect of prenatal vitamin supplementation on lower-genital levels of HIV type 1 and interleukin type 1 beta at 36 weeks of gestation. Clin Infect Dis 2004;38:716-22.
7. Fawzi WW, Msamanga GI, Spiegelman D, et al. A randomized trial of multivitamin supplements and HIV disease progression and mortality. N Engl J Med 2004;351:23-32.
8. World Health Organization. Interim proposal for a WHO staging system for HIV infection and disease. Wkly Epidemiol Rec 1990;65:221-4.
9. Ghosh MK, Kuhn L, West J, et al. Quantitation of human immunodeficiency virus type 1 in breast milk. J Clin Microbiol 2003;41:2465-70.
10. Koulinska IN, Villamor E, Chaplin B, et al. Transmission of cell-free and cell-associated HIV-1 through breast-feeding. J Acquir Immune Defic Syndr 2006;41:93-9.
11. Webb AL, Aboud S, Furtado J, et al. Effect of vitamin supplementation on breast milk concentrations of retinol, carotenoids and tocopherols in HIV-infected Tanzanian women. Eur J Clin Nutr 2009;63:332-9.
12. Semba RD, Kumwenda N, Hoover DR, et al. Human immunodeficiency virus load in breast milk, mastitis, and mother-to-child transmission of human immunodeficiency virus type 1. J Infect Dis 1999;180:93-8.
13. MacDonald KS, Malonza I, Chen DK, et al. Vitamin A and risk of HIV-1 seroconversion among Kenyan men with genital ulcers. AIDS 2001;15:635-9.
14. Moriuchi H, Moriuchi M, Fauci AS. Differentiation of promonocytic U937 subclones into macrophagelike phenotypes regulates a cellular factor(s) which modulates fusion/entry of macrophagetropic human immunodeficiency virus type 1. J Virol 1998;72:3394-400.
15. Guay LA, Hom DL, Mmiro F, et al. Detection of human immunodeficiency virus type 1 (HIV-1) DNA and p24 antigen in breast milk of HIV-1-infected Ugandan women and vertical transmission. Pediatrics 1996;98:438-44.
16. Southern SO. Milk-borne transmission of HIV. Characterization of productively infected cells in breast milk and interactions between milk and saliva. J Hum Virol 1998;1:328-37.
17. Kantarci S, Koulinska IN, Aboud S, Fawzi WW, Villamor E. Subclinical mastitis, cell-associated HIV-1 shedding in breast milk, and breast-feeding transmission of HIV-1. J Acquir Immune Defic Syndr 2007;46: 651-4.
18. Filteau SM, Rice AL, Ball JJ, et al. Breast milk immune factors in Bangladeshi women supplemented postpartum with retinol or betacarotene. Am J Clin Nutr 1999;69:953-8.
19. Hindle LJ, Gitau R, Filteau SM, et al. Effect of multiple micronutrient supplementation during pregnancy on inflammatory markers in Nepalese women. Am J Clin Nutr 2006;84:1086-92.
20. Gomo E, Filteau SM, Tomkins AM, Ndhlovu P, Michaelsen KF, Friis H. Subclinical mastitis among HIV-infected and uninfected Zimbabwean women participating in a multimicronutrient supplementation trial. Trans R Soc Trop Med Hyg 2003;97:212-6.
21. Omenn GS, Goodman GE, Thornquist MD, et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996;334:1150-5.
22. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. N Engl J Med 1994;330:1029-35.
23. Tornwall ME, Virtamo J, Korhonen PA, et al. Effect of alpha-tocopherol and beta-carotene supplementation on coronary heart disease during the 6-year post-trial follow-up in the ATBC study. Eur Heart J 2004;25:1171-8.
24. Palozza P. Prooxidant actions of carotenoids in biologic systems. Nutr Rev 1998;56:257-65.
25. McGill CR, Green NR, Meadows MC, Gropper SS. Beta-carotene supplementation decreases leukocyte superoxide dismutase activity and serum glutathione peroxidase concentration in humans. J Nutr Biochem 2003;14:656-62.
26. Siems W, Wiswedel I, Salerno C, et al. Beta-carotene breakdown products may impair mitochondrial functions-potential side effects of high-dose beta-carotene supplementation. J Nutr Biochem 2005;16:385-97.
27. Coodley GO, Coodley MK, Lusk R, et al. Beta-carotene in HIV infection: an extended evaluation. AIDS 1996;10:967-73.
28. Nimmagadda AP, Burri BJ, Neidlinger T, O'Brien WA, Goetz MB. Effect of oral beta-carotene supplementation on plasma human immunodeficiency virus (HIV) RNA levels and CD4+ cell counts in HIV-infected patients. Clin Infect Dis 1998;27:1311-3.
29. Austin J, Singhal N, Voigt R, et al. A community randomized controlled clinical trial of mixed carotenoids and micronutrient supplementation of patients with acquired immunodeficiency syndrome. Eur J Clin Nutr 2006;60:1266-76.
30. Lietz G, Henry CJ, Mulokozi G, et al. Comparison of the effects of supplemental red palm oil and sunflower oil on maternal vitamin A status. Am J Clin Nutr 2001;74:501-9.
31. Radhika MS, Bhaskaram P, Balakrishna N, Ramalakshmi BA. Red palm oil supplementation: a feasible diet-based approach to improve the vitamin A status of pregnant women and their infants. Food Nutr Bull 2003;24:208-17.
32. Humphrey JH, Iliff PJ, Marinda ET, et al. Effects of a single large dose of vitamin A, given during the postpartum period to HIV-positive women and their infants, on child HIV infection, HIV-free survival, and mortality. J Infect Dis 2006;193:860-71.